Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-02 @ 2:38 AM
Study NCT ID:
NCT00303251
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2006-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-03-14
First Submit QC Date:
None
Study First Post Date:
2006-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-02-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-03-09
Last Update Post Date:
2021-03-11
Last Update Post Date Type:
ACTUAL